Clinical trial
Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease
NCT00296959 · University Health Network, Toronto, Other · Terminated
Key facts
| NCT number | NCT00296959 |
|---|---|
| Title | Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease |
| Official title | Anti-Dyskinetic Properties of Topiramate: A Double-Blind, Placebo-Controlled Trial in Patients With Parkinson's Disease and Levodopa-Induced Dyskinesias |
| Lead sponsor | University Health Network, Toronto, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | topiramate (drug) |
| Enrollment | 20 |
| Start date | Sep 1, 2004 |
| Completion | Mar 1, 2007 |
| First posted | Feb 27, 2006 |
| Last update posted | Sep 20, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: